Structure-function and regulation of ADAMTS-13 protease

115Citations
Citations of this article
155Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

ADAMTS-13, a plasma reprolysin-like metalloprotease, cleaves von Willebrand factor (VWF). Severe deficiency of plasma ADAMTS-13 activity results in thrombotic thrombocytopenic purpura (TTP), while mild to moderate deficiencies of plasma ADAMTS-13 activity are emerging risk factors for developing myocardial and cerebral infarction, pre-eclampsia, and malignant malaria. Moreover, Adamts13-/- mice develop more severe inflammatory responses, leading to increased ischemia/perfusion injury and formation of atherosclerosis. Structure-function studies demonstrate that the N-terminal portion of ADAMTS-13 (MDTCS) is necessary and sufficient for proteolytic cleavage of VWF under various conditions and attenuation of arterial/venous thrombosis after oxidative injury. The more distal portion of ADAMTS-13 (TSP1 2-8 repeats and CUB domains) may function as a disulfide bond reductase to prevent an elongation of ultra-large VWF strings on activated endothelial cells and inhibit platelet adhesion/aggregation on collagen surface under flow. Remarkably, the proteolytic cleavage of VWF by ADAMTS-13 is accelerated by FVIII and platelets under fluid shear stress. A disruption of the interactions between FVIII (or platelet glycoprotein 1bα) and VWF dramatically impairs ADAMTS-13-dependent proteolysis of VWF in vitro and in vivo. These results suggest that FVIII and platelets may be physiological cofactors regulating VWF proteolysis. Finally, the structure-function and autoantibody mapping studies allow us to identify an ADAMTS-13 variant with increased specific activity but reduced inhibition by autoantibodies in patients with acquired TTP. Together, these findings provide novel insight into the mechanism of VWF proteolysis and tools for the therapy of acquired TTP and perhaps other arterial thrombotic disorders. © 2013 International Society on Thrombosis and Haemostasis.

References Powered by Scopus

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura

1690Citations
N/AReaders
Get full text

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1577Citations
N/AReaders
Get full text

Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1566Citations
N/AReaders
Get full text

Cited by Powered by Scopus

ADAMTS13 and von willebrand factor in thrombotic thrombocytopenic purpura

182Citations
N/AReaders
Get full text

Update on von Willebrand factor multimers: Focus on high-molecular-weight multimers and their role in hemostasis

167Citations
N/AReaders
Get full text

Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics

128Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zheng, X. L. (2013, June). Structure-function and regulation of ADAMTS-13 protease. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/jth.12221

Readers over time

‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘2407142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 62

63%

Researcher 19

19%

Professor / Associate Prof. 15

15%

Lecturer / Post doc 3

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 45

45%

Agricultural and Biological Sciences 30

30%

Biochemistry, Genetics and Molecular Bi... 18

18%

Chemistry 6

6%

Save time finding and organizing research with Mendeley

Sign up for free
0